Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze BPOP stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate BPOP investment potential.

What is BPOP stock price today?

Get real-time BPOP stock price, historical data, and price charts on Financhill. Track BPOP performance with our advanced analysis tools.

Is BPOP a good investment?

Evaluate BPOP investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy BPOP stock?

To buy BPOP stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of BPOP?

View detailed market capitalization data and company valuation metrics for BPOP on our comprehensive analysis page.

What is the P/E ratio of BPOP?

Use our fundamental analysis tools to view BPOP P/E ratio and compare valuation metrics with industry peers.

What are BPOP earnings?

View BPOP earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Popular, Inc. 10K Form

Buy

BPOP
Popular, Inc.

Last Price:

$133.46

Seasonality Move:

7.81%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-10	10Q	BPOP/Popular, Inc. Quarterly
2023-11-09	10Q	BPOP/Popular, Inc. Quarterly
2023-08-09	10Q	BPOP/Popular, Inc. Quarterly
2023-05-10	10Q	BPOP/Popular, Inc. Quarterly
2022-11-09	10Q	BPOP/Popular, Inc. Quarterly
2022-08-09	10Q	BPOP/Popular, Inc. Quarterly

Receive BPOP News And Ratings

See the #1 stock for the next 7 days that we like better than BPOP

BPOP Financial Statistics

Sales & Book Value

Annual Sales:	$4.5B
Cash Flow:	$148M
Price / Cash Flow:	14.25
Annual Sales:	$94.75
Price / Book:	1.41

Profitability

EPS (TTM):	12.31620
Net Income (TTM):	$833.2M
Gross Margin:	$0
Return on Equity:	14.01%
Return on Assets:	1.12%

Popular, Inc. Earnings Forecast

Key Popular, Inc. Financial Ratios

The Gross Profit Margin over the past 43 years for BPOP is 0.00%.
The Selling, General & Administrative Expenses for BPOP have been equal to 0.00% of Gross Profit Margin.
The Interest Expense is 7.67% of Operating Income.
The Net Earning history of BPOP is 18.70% of Total Revenues.
Per Share Earnings over the last 43 years have been positive in 24 years.

Popular, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Banks
Sector:	Financials
Current Symbol:	BPOP
CUSIP:	733174
Website:	popular.com

Debt

Debt-to-Equity Ratio:	0.23
Current Ratio:	0.2
Quick Ratio:	0

Price-to-Earnings

Trailing P/E Ratio:	10.83
Forward P/E Ratio:	8.37

BPOP Technical Analysis vs Fundamental Analysis

Buy

Popular, Inc. (BPOP) is a Buy

Is Popular, Inc. a Buy or a Sell?

Popular, Inc. stock is rated a Buy

The current Popular, Inc. [BPOP] share price is $133.25. The Score for BPOP is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.